Grail’s shares plummeted more than 45% after-hours Thursday as the medtech revealed a major National...
Grail
Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings...
Grail saw a sharp rise in third-quarter sales as it outlined a firmer FDA submission...
Grail is on a mission to have its cancer blood test become a core part...